Literature DB >> 15331191

Interstitial lung disease in the patient who has connective tissue disease.

Charlie Strange1, Kristin B Highland.   

Abstract

Interstitial lung disease is a common complication of many of the connective tissue diseases. Because the prognosis, degree of reversibility, and optimal therapy differs for each disease presentation, a thorough knowledge of the pulmonary presentations of each connective tissue disease is important. Additionally, the challenge of finding the patient who has occult connective tissue disease in an interstitial lung disease clinic is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331191     DOI: 10.1016/j.ccm.2004.05.009

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  23 in total

1.  Reasons for coming to hospital after treatment for community-acquired pneumonia on an ambulatory basis.

Authors:  Mohammedreza Shariatzadeh; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-04       Impact factor: 2.409

2.  Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

Authors:  Sarah Geerts; Wim Wuyts; Ellen De Langhe; Jan Lenaerts; Jonas Yserbyt
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 3.  Subclinical interstitial lung disease: why you should care.

Authors:  Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2012-02-23       Impact factor: 21.405

4.  Autoimmune-featured interstitial lung disease: a distinct entity.

Authors:  Rekha Vij; Imre Noth; Mary E Strek
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

5.  Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases.

Authors:  Jared T Hagaman; Ralph J Panos; Francis X McCormack; Charuhas V Thakar; Kathryn A Wikenheiser-Brokamp; Ralph T Shipley; Brent W Kinder
Journal:  Chest       Date:  2010-08-05       Impact factor: 9.410

6.  Connective tissue disease-associated interstitial lung disease: a call for clarification.

Authors:  Aryeh Fischer; Sterling G West; Jeffrey J Swigris; Kevin K Brown; Roland M du Bois
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

7.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; David A Lynch; Gregory P Downey; Gregory P Cosgrove; Stephen K Frankel; Evans R Fernandez-Perez; JoAnn Z Gillis; Kevin K Brown
Journal:  Respir Med       Date:  2009-06-03       Impact factor: 3.415

9.  Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; Steve D Groshong; Carlyne D Cool; Hakan Sahin; David A Lynch; JoAnn Z Gillis; Marc D Cohen; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2009-05-08       Impact factor: 9.410

10.  BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Authors:  Anthony K Shum; Mohammad Alimohammadi; Catherine L Tan; Mickie H Cheng; Todd C Metzger; Christopher S Law; Wint Lwin; Jaakko Perheentupa; Helene Bour-Jordan; Jean Claude Carel; Eystein S Husebye; Filippo De Luca; Christer Janson; Ravishankar Sargur; Noémie Dubois; Merja Kajosaari; Paul J Wolters; Harold A Chapman; Olle Kämpe; Mark S Anderson
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.